Tecan Group AG (LTS:0QLN) ROCE %: 2.46% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QLN Tecan Group AG LTS:0QLN
77 GF Score
Price CHF191.24
GF Value CHF187.28
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Tecan Group AG ROCE %?

Tecan Group AG LTS:0QLN +1.06% 77 ROCE % is 2.46% as of Jun. 2026. GuruFocus rates LTS:0QLN with a GF Score™ of 77/100 and a GF Value™ of CHF187.28 (Fairly Valued). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tecan Group AG's annualized ROCE % for the quarter that ended in Jun. 2026 was 2.46%.

Tecan Group AG  (LTS:0QLN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tecan Group AG ROCE % Related Terms

Tecan Group AG ROCE % Historical Data

* Premium members only.

The historical data trend for Tecan Group AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tecan Group AG ROCE % Chart

Tecan Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.04 8.30 7.60 4.84 -6.54

Tecan Group AG Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.33 6.03 3.26 -17.28 2.46
LTS:0QLN
77GF Score
Tecan Group AG LTS:0QLN
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tecan Group AG ROCE % Calculation

Tecan Group AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-98.11/( ( (2121.483 - 531.252) + (1698.089 - 288.754) )/ 2 )
=-98.11/( (1590.231+1409.335)/ 2 )
=-98.11/1499.783
=-6.54 %

Tecan Group AG's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Dec. 2025 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Dec. 2025 )(Q: Jun. 2026 )
=34.08/( ( (1698.089 - 288.754) + (1647.875 - 281.916) )/ 2 )
=34.08/( ( 1409.335 + 1365.959 )/ 2 )
=34.08/1387.647
=2.46 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 2.46% mean?
Tecan Group AG (LTS:0QLN) has a ROCE % of 2.46% as of Jun. 2026.
Is Tecan Group AG's ROCE % too high?
Tecan Group AG's current ROCE % is 2.46%. The Medical Devices & Instruments industry median ROCE % is 2.93. Tecan Group AG's value of 2.46% is 16% below this industry median. Overall, Tecan Group AG has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's ROCE % compare to ISRG and BDX?
Tecan Group AG's ROCE % of 2.46% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.93. Tecan Group AG's value of 2.46% is 16% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.93, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tecan Group AG's current ROCE % of 2.46% is 16% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tecan Group AG's current ROCE % is 2.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Based on GuruFocus' analysis, Tecan Group AG (LTS:0QLN) is currently considered Fairly Valued. The stock's GF Value™ is CHF187.28, compared to a current price of CHF191.24 — trading 2.1% above its estimated fair value. The current ROCE % is 2.46% and 16% below the Medical Devices & Instruments industry median of 2.93. Tecan Group AG's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Tecan Group AG (LTS:0QLN), the current ROCE % is 2.46% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tecan Group AG (LTS:0QLN) Overvalued in 2026?

Based on GuruFocus' analysis, Tecan Group AG stock appears to be overvalued. The current stock price of CHF191.24 is trading 2.1% above its estimated GF Value™ of CHF187.28. GuruFocus considers Tecan Group AG to be Fairly Valued.

Key valuation signals for LTS:0QLN:

  • ROCE %: 2.46%
  • GF Value™: CHF187.28 vs. price of CHF191.24 (2.1% above fair value)
  • GF Score™: 77/100 with 8 warning signs
  • Industry Position: 16% below the Medical Devices & Instruments median

No single metric tells the full story. See the LTS:0QLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tecan Group AG Business Description

Address Seestrasse 103, Mannedorf, CHE, 8708
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
77GF Score

Get the complete analysis for LTS:0QLN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF191.24
Price
CHF187.28
GF Value